Thank you for attending: Update on Diabetes XLII
Date: Thursday, April 11, 2019
Time: 7:40 a.m. to 4:30 p.m.
Up to 7 CME credits. Breakfast and lunch will be provided.
Who should attend?
Practicing physicians, house officers, physician assistants, nurse practitioners, and other medical personnel that treat or educate patients with diabetes.
More details to come! For any questions, please contact:
Lynne J. Brecker, RN, BSN, Certified Diabetes Educator at MedStar Union Memorial Hospital
[email protected] | 410-554-4527
Location:
MedStar Union Memorial Hospital | Conference Center
201 E. University Parkway, Baltimore, MD 21218
Free parking is available at the Homewood garage, 2600 block of Charles Street.
Shuttle service is available.
Cost:
$150.00 for practicing physicians
$75.00 for house officers, physician's assistants, nurse practitioners and other medical personnel.
Registration:
Reserve your spot by calling 866-493-1977 to register or register online.
Registration deadline: April 6, 2019
Course participants desiring overnight accommodations should contact the Diabetes and Endocrine Center at MedStar Union
Memorial Hospital at 410-554-4527 for suggestions.
Learn more about Diabetes and Endocrinology at MedStar Union Memorial.
Program Schedule
Issam Cheikh, MD – Presiding
7:40 a.m. Registration and Continental Breakfast
8 a.m. Welcome and Introductory Remarks
Dana H. Frank, MD
8:05 a.m. Pathophysiology, Diagnosis, Complications, and Management of Lipodystrophy
Rebecca J. Brown, MD
8:55 a.m. Diabetes Mellitus - Contributing Factors
Rani S. Kulkarni, MD
9:35 a.m. Gestational Diabetes Update
Pamela R. Schroeder, MD
10:10 a.m. Antiplatelet Therapy for Primary Prevention in Diabetes
Ariane C. Davis, MD
10:45 a.m. Coffee Break
11:05 a.m. What Causes Hypoglycemia
Adline Ghazi, MD
11:40 a.m. Evolving Changes in Orthopaedic Treatment of the Diabetic Foot
Stuart D. Miller, MD
12:25 p.m. Lunch Break
Mansur Shomali, MD – Presiding
1:25 p.m. Diabetes and the Kidney
Malek E. Cheikh, MD
2 p.m. Medical and Surgical Aspects of Bariatric Surgery
Paul A. Sack, MD, and Alain E. Abdo, MD
2:55 p.m. Leaping Forward: CGM and Closing the Loop 2019
Nicholas B. Argento, MD
3:40 p.m. How to Choose the Right Therapy for Type 2 Diabetes
Mansur E. Shomali, MD
4:25 p.m. Summary and Closing Remarks
Issam E. Cheikh, MD
4:35 p.m. Adjourn
Meet the Speakers
Issam E. Cheikh, MD, FACP, FACE
Chief, Division of Endocrinology and Metabolism
Director, Diabetes and Endocrine Center
MedStar Union Memorial Hospital
Adjunct Professor of Medicine
University of Maryland School of Medicine
Planning Committee
The topics for Update on Diabetes XLII were selected to update the attendees on the latest scientific data and clinical applications for the research of diabetes. The program was assembled by Dr. Issam Cheikh and the MedStar Union Memorial Endocrinology faculty.
Course Goals and Objectives
Target Audience
This program is designed to be a multidisciplinary program and is intended for a wide range of medical practitioners who are interested in the latest information on the treatment of diabetes. The program is targeted for hospital-based physicians, community physicians, fellows, residents, medical students, nurse practitioners, physician assistants, nurses, pharmacists, dietitians/nutritionists, and other members of the healthcare team who have an interest in the treatment of diabetes.
Learning Objectives
Upon completion of this program, participants will be able to:
- Explain how to diagnose and manage patients with lipodystrophy syndromes.
- Identify the potential causes of secondary diabetes.
- Recognize the screening tests, diagnosis, and maternal and fetal risks associated with gestational diabetes mellitus and explain the treatment options for gestational diabetes mellitus including dietary modification, physical activity, oral agents, and insulins.
- Describe the efficacy of aspirin, dual antiplatelet therapy, and fatty acid supplements for primary prevention in persons with diabetes.
- Indicate common causes of hypoglycemia in individuals with and without diabetes and formulate a systematic diagnostic approach to hypoglycemia.
- Illuminate the latest concepts and advances in orthopaedic care of patients with diabetic foot pathology.
- Define the optimal medical therapy for patients with diabetes and chronic kidney disease.
- Review the clinical benefits of weight loss procedures and the impact of bariatric surgery for patients with Type 2 diabetes.
- Summarize key features of modern Continuous Glucose Monitoring systems and the available partial closed loop insulin pumps.
- Effectively prescribe and adjust diabetes medications and treatments based on recent scientific advancements with a patient-centered focus.
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by MedStar Health. MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC) and the American Academy of PAs (AAPA) to provide continuing education for the healthcare team.
Credit Designation
This activity was planned by and for the healthcare team, and learners will receive seven Interprofessional Continuing Education (IPCE) credits for learning and change.
This activity has been approved for 7 AOA Category 2-A CME credits with the American Osteopathic Association. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MedStar Union Memorial Hospital reserves the right to cancel any educational program due to unforeseen circumstances.
The topics for Update on Diabetes XLII were chosen to give an overview of the advances in diabetes care. The faculty of this program has been selected from local and national experts for the ability of these speakers to present complicated and new information clearly and authoritatively. After this activity, the knowledge gained from attending this symposium will enable attendees to improve the care of patients with diabetes.